These findings support the proposition that mSWI/SNF functions as a tumor suppressor while remaining essential for cancer cell growth21,22,80 and further suggest that its dosage-sensitive regulatory effects contribute to cancer progression, particularly via control of MYC oncogene activation. The gene discussed is MYC; the disease is neoplasm.